Results 21 to 30 of about 941,634 (294)

Regulatory T cells in autoimmune hepatitis: an updated overview

open access: yesJournal of Autoimmunity, 2021
Regulatory T-cells (Tregs) are key players in the maintenance of immune homeostasis by preventing immune responses to self-antigens. Defects in Treg frequency and/or function result in overwhelming CD4 and CD8 T cell immune responses participating in the
M. Longhi, G. Mieli-Vergani, D. Vergani
semanticscholar   +1 more source

Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

open access: yesHepatology, 2021
Data regarding outcome of COVID‐19 in patients with autoimmune hepatitis (AIH) are lacking.
C. Efe   +47 more
semanticscholar   +1 more source

Atypical presentation of autoimmune hepatitis–primary sclerosing cholangitis overlap syndrome associated with hypereosinophilia: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2021
Background Autoimmune hepatitis–primary sclerosing cholangitis overlap syndrome is a form of autoimmune hepatitis with cholestatic features and is characterized by negative anti-mitochondrial antibody and cholangiographic changes on magnetic resonance ...
Behzad Hatami   +2 more
doaj   +1 more source

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

open access: yesHepatology International, 2021
Autoimmune hepatitis (AIH) is not a common disease but with increasing incidence in Asia–Pacific area. Although the etiology and pathogenesis are not completely clear, the disease is the result of loss of autoimmune tolerance in genetically predisposed ...
Guiqiang Wang   +19 more
semanticscholar   +1 more source

Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis

open access: yesEinstein (São Paulo), 2023
Objective Published studies have shown associations between anti-ribosomal P (anti-P) antibody and systemic lupus erythematosus with hepatic manifestations. This has been reported also in autoimmune hepatitis.
Clarisse de Almeida Gallo   +6 more
doaj   +1 more source

An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A

open access: yesAnnals of Hepatology, 2020
There are rare instances where patients with acute hepatitis A virus infection subsequently developed autoimmune hepatitis. The diagnosis of autoimmune hepatitis in this setting is challenging. Furthermore, information on treatment with steroids or other
Vijay S.-Are   +5 more
doaj   +1 more source

Autoimmune hepatitis

open access: yesJournal of Hepatology, 2000
Autoimmune hepatitis (AIH) is a rare disease, characterized by female predominance, hypergammaglobulinemia, autoantibodies, association with HLA DR3 and HLA DR4 and a good response to immunosuppression. Different subtypes of AIH may be distinguished, based on differences in the autoantibody patterns.
P, Obermayer-Straub   +2 more
  +7 more sources

Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease

open access: yesFrontiers in Medicine, 2021
Background: The impact of the influenza A (H1N1) and SARS-CoV-2 virus on the development of autoimmune hepatitis has not been described previously.Methods: In this case series, we evaluated the dynamic changes in liver function of three patients with ...
Qian Li   +9 more
doaj   +1 more source

New treatments/targets for primary biliary cholangitis

open access: yesJHEP Reports, 2019
Summary: Primary biliary cholangitis (PBC) is an autoimmune, cholestatic, chronic liver disease that ultimately progresses towards cirrhosis and liver failure if untreated.
Christophe Corpechot   +2 more
doaj   +1 more source

Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?

open access: yesJournal of Autoimmunity, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been reported to trigger several autoimmune diseases. There are also recent reports of autoimmune diseases that develop after SARS-CoV-2 vaccines.
E. Avcı, F. Abasiyanik
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy